Multilevel analyses of on-demand medication data, with an application to the treatment of Female Sexual Interest/Arousal Disorder

被引:3
|
作者
Kessels, Rob [1 ]
Bloemers, Jos [1 ,2 ,3 ]
Tuiten, Adriaan [1 ]
van der Heijden, Peter G. M. [4 ,5 ]
机构
[1] Emot Brain BV, Almere, Flevoland, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
[3] Univ Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands
[4] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands
[5] Univ Southampton, Dept Social Sci, Southampton, Hants, England
来源
PLOS ONE | 2019年 / 14卷 / 08期
关键词
REFLUX SYMPTOMS; EFFICACY; MODELS; AROUSAL; SAFETY;
D O I
10.1371/journal.pone.0221063
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data from clinical trials investigating on-demand medication often consist of an intentionally varying number of measurements per patient. These measurements are often observations of discrete events of when the medication was taken, including for example data on symptom severity. In addition to the varying number of observations between patients, the data have another important feature: they are characterized by a hierarchical structure in which the events are nested within patients. Traditionally, the observed events of patients are aggregated into means and subsequently analyzed using, for example, a repeated measures ANOVA. This procedure has drawbacks. One drawback is that these patient means have different standard errors, first, because the variance of the underlying events differs between patients and second, because the number of events per patient differs. In this paper, we argue that such data should be analyzed by applying a multilevel analysis using the individual observed events as separate nested observations. Such a multilevel approach handles this drawback and it also enables the examination of varying drug effects across patients by estimating random effects. We show how multilevel analyses can be applied to on-demand medication data from a clinical trial investigating the efficacy of a drug for women with low sexual desire. We also explore linear and quadratic time effects that can only be performed when the individual events are considered as separate observations and we discuss several important statistical topics relevant for multilevel modeling. Taken together, the use of a multilevel approach considering events as nested observations in these types of data is advocated as it is more valid and provides more information than other (traditional) methods.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] FEMPROX®, A TOPICAL ALPROSTADIL CREAM TREATMENT CONVEYS SUSTAINED IMPROVEMENT OF SEXUAL AROUSAL, LUBRICATION AND DESIRE IN WOMEN SUFFERING FROM FEMALE SEXUAL AROUSAL DISORDER (FSAD)
    Goldstein, I
    Damaj, B.
    Fernando, Y.
    Frank, D.
    Moncada, I
    [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 325 - 325
  • [42] Female Sexual Interest and Arousal Disorder How We Can Help When Our Patient's Libido Hits the Brakes
    McKenzie, Nisha
    [J]. PHYSICIAN ASSISTANT CLINICS, 2018, 3 (03) : 385 - +
  • [43] Response to Balon and Clayton (2014): Female Sexual Interest/Arousal Disorder Is a Diagnosis More on Firm Ground than Thin Air
    Graham, Cynthia A.
    Brotto, Lori A.
    Zucker, Kenneth J.
    [J]. ARCHIVES OF SEXUAL BEHAVIOR, 2014, 43 (07) : 1231 - 1234
  • [44] Response to Balon and Clayton (2014): Female Sexual Interest/Arousal Disorder Is a Diagnosis More on Firm Ground than Thin Air
    Cynthia A. Graham
    Lori A. Brotto
    Kenneth J. Zucker
    [J]. Archives of Sexual Behavior, 2014, 43 : 1231 - 1234
  • [45] Partner Responses to Low Desire: Associations With Sexual, Relational, and Psychological Well-Being Among Couples Coping With Female Sexual Interest/Arousal Disorder
    Rosen, Natalie O.
    Corsini-Munt, Serena
    Dube, Justin P.
    Boudreau, Carmen
    Muise, Amy
    [J]. JOURNAL OF SEXUAL MEDICINE, 2020, 17 (11): : 2168 - 2180
  • [46] A Randomized Trial Comparing Group Mindfulness-Based Cognitive Therapy With Group Supportive Sex Education and Therapy for the Treatment of Female Sexual Interest/Arousal Disorder
    Brotto, Lori A.
    Zdaniuk, Bozena
    Chivers, Meredith L.
    Jabs, Faith
    Grabovac, Andrea
    Lalumiere, Martin L.
    Weinberg, Joanne
    Schonert-Reichl, Kimberly A.
    Basson, Rosemary
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2021, 89 (07) : 626 - 639
  • [47] Feasibility and Acceptability of a Group-Based Mindfulness Intervention for Sexual Interest/Arousal Disorder Following Breast Cancer Treatment
    Sears, Carly
    Millman, Roanne
    Brotto, Lori A.
    Walker, Lauren M.
    [J]. JOURNAL OF SEX & MARITAL THERAPY, 2023, 49 (05) : 533 - 549
  • [48] Comparison of the effect of Elaeagnus angustifolia flower capsule and sildenafil citrate tablet female sexual interest/arousal disorder in clinical trial study
    Zeinalzadeh, Sanaz
    Mohagheghzadeh, Abdol Ali
    Ahmadinezhad, Fatemeh
    Akbarzadeh, Marzieh
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (11) : 3614 - 3620
  • [49] Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo controlled study
    Berman, JR
    Berman, LA
    Toler, SM
    Gill, J
    Haughie, S
    [J]. JOURNAL OF UROLOGY, 2003, 170 (06): : 2333 - 2338
  • [50] Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides
    Pryde, David C.
    Maw, Graham N.
    Planken, Simon
    Platts, Michelle Y.
    Sanderson, Vivienne
    Corless, Martin
    Stobie, Alan
    Barber, Christopher G.
    Russell, Rachel
    Foster, Laura
    Barker, Laura
    Wayman, Christopher
    Van der Graaf, Piet
    Stacey, Peter
    Morren, Debbie
    Kohl, Christopher
    Beaumont, Kevin
    Coggon, Sara
    Tute, Michael
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4409 - 4424